Origin Therapeutics Holdings, Inc. Income Statement
Last quarter (Q3 2024), Origin Therapeutics Holdings, Inc.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Origin Therapeutics Holdings, Inc.'s net income was $-574.15K. See Origin Therapeutics Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 23
Sep 22
Sep 21
Total Revenue
$ ―
$ ―
$ ―
Gross Profit
$ ―
$ ―
$ ―
Operating Expenses
$ ―
$ ―
$ ―
Depreciation and Amortization
$ ―
$ ―
$ ―
EBITDA
$ ―
$ -1.45M
$ -1.19M
Operating Income
$ ―
$ -1.21M
$ -1.19M
Other Income/Expenses
$ ―
$ ―
$ ―
Pretax Income
$ ―
$ ―
$ ―
Net Income
$ -6.31M
$ -1.45M
$ -845.51K
Per Share Metrics
Basic EPS
$ ―
$ ―
$ ―
Diluted EPS
$ ―
$ ―
$ ―
Weighted Average Shares Outstanding
―
―
―
Weighted Average Shares Outstanding (Diluted)
―
―
―
Currency in USD
Origin Therapeutics Holdings, Inc. Earnings and Revenue History